FDA prohibits Ranbaxy API plant from producing and distributing products for US market
11:11 AM | January 24, 2014 | Deepti Ramesh
The US Food and Drug Administration (FDA) announced on 23 January that it has notified Ranbaxy Laboratories (Gurgaon, India), that it is prohibited from manufacturing and distributing active...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.